ライフサイエンスコーパス: peroxisome proliferator-activated receptor gamma

1 nhanced serine 273 phosphorylation of Pparg (peroxisome proliferator-activated receptor gamma).

2 3(nur12) mice or in mice given inhibitors of peroxisome proliferator-activated receptor gamma.

3 adipogenic differentiation was mediated via peroxisome proliferator-activated receptor gamma.

4 n of CCAAT/enhancer-binding protein beta and peroxisome proliferator-activated receptor gamma.

5 timulates adipogenesis via CB1 receptors and peroxisome proliferator-activated receptor gamma.

6 lta-prostaglandin J2-dependent activation of peroxisome proliferator-activated receptor gamma.

7 macologic inhibitors of cyclooxygenase 2 and peroxisome proliferator-activated receptor gamma.

8 fects thought to be due to activation of the peroxisome proliferator-activated receptor gamma.

9 on of the proadipogenic transcription factor peroxisome proliferator-activated receptor-gamma.

10 direct consequence of very low expression of peroxisome proliferator-activated receptor gamma 2 (PPAR

11 ver development by suppressing expression of peroxisome proliferator-activated receptor gamma 2 and l

12 id not alter preadipocyte factor 1 (Dlk1) or peroxisome proliferator-activated receptor-gamma 2 (Ppar

13 Activating peroxisome proliferator-activated receptor gamma, a down

14 gnificant reduction in hepatic expression of peroxisome proliferator-activated receptor-gamma, a nucl

15 In addition, the chromatin accessibility of peroxisome proliferator-activated receptor-gamma accompa

16 regulated at the transcriptional level in a peroxisome proliferator-activated receptor gamma activat

17 Peroxisome proliferator activated receptor gamma-activat

18 ented the inflammatory response dependent on peroxisome proliferator-activated receptor gamma activit

19 vels of the anti-inflammatory nuclear factor peroxisome proliferator activated receptor-gamma after s

20 N-terminal kinase inhibitor SP600125 and the peroxisome proliferator-activated receptor gamma agonist

21 ented and even partially reversed ex vivo by peroxisome proliferator-activated receptor-gamma agonist

22 ipeptidyl peptidase-IV inhibitors as well as peroxisome proliferator-activated receptor-gamma agonist

23 Furthermore, we show that peroxisome proliferator-activated receptor-gamma agonist

24 a healthy human (mini-)organ, and show that peroxisome proliferator-activated receptor-gamma agonist

25 Peroxisome proliferator-activated receptor-gamma agonist

26 Pbeta), which regulates the transcription of peroxisome proliferator-activated receptor gamma and C/E

27 and FOXO1; however, increased expression of peroxisome proliferator-activated receptor gamma and CCA

28 nservation than the full proteins, while the peroxisome proliferator-activated receptor gamma and cor

29 lta-prostaglandin J2-dependent activation of peroxisome proliferator-activated receptor gamma and mac

30 ated protein 2 expression and suppression of peroxisome proliferator-activated receptor gamma and p27

31 EM1, increased transcriptional activation of peroxisome proliferator-activated receptor gamma and pro

32 In addition, the up-regulated peroxisome proliferator-activated receptor-gamma and -al

33 The expression of peroxisome proliferator-activated receptor-gamma and CAA

34 ung protein showed significant reductions in peroxisome proliferator-activated receptor-gamma and CD3

35 ing STAT3, STAT6, Kruppel-like factor 4, and peroxisome proliferator-activated receptor gamma, and ca

36 ation markers; fatty acid binding protein 4, peroxisome proliferator-activated receptor gamma, and GL

37 has shown that phosphorylation of PPARgamma (peroxisome proliferator-activated receptor gamma) at ser

38 int of communication between the miR-130/301-peroxisome proliferator-activated receptor gamma axis in

39 vels of insulin receptor substrate 1 (IRS1), peroxisome proliferator-activated receptor gamma, CCAAT/

40 The co-activator, peroxisome proliferator-activated receptor gamma co-acti

41 criptional regulator of cell metabolism, the peroxisome proliferator-activated receptor gamma co-acti

42 cAMP response element consensus sequence on peroxisome proliferator-activated receptor gamma co-acti

43 likely mediated by the nuclear co-activators peroxisome proliferator-activated receptor gamma co-acti

44 induce the expression of the genes encoding peroxisome proliferator-activated receptor gamma co-acti

45 Erk5 regulation of peroxisome proliferator-activated receptor gamma co-acti

46 that ERRalpha and its obligate co-activator, peroxisome proliferator-activated receptor gamma co-acti

47 s, including uncoupling protein 1 (Ucp1) and peroxisome proliferator-activated receptor gamma co-acti

48 on the transcription coactivator PGC-1beta (peroxisome proliferator-activated receptor-gamma co-acti

49 al LPS exposure led to pre-existing elevated peroxisome proliferators-activated receptor-gamma co-act

50 tors of mitochondrial biogenesis, PPARgamma (peroxisome proliferator-activated receptor gamma) coacti

51 Peroxisome proliferator activated receptor gamma, coacti

52 he mitochondrial transcriptional coactivator peroxisome proliferator-activated receptor gamma, coacti

53 ral components of the liver clock, including peroxisome proliferator-activated receptor-gamma, coacti

54 ells with and without lipid loading based on peroxisome proliferator activated receptor gamma coactiv

55 Peroxisome proliferator activated receptor gamma coactiv

56 Peroxisome proliferator activated receptor gamma coactiv

57 fat gene programs involve the suppression of peroxisome proliferator activated receptor gamma coactiv

58 ncludes converging evidence identifying that peroxisome proliferator activated receptor gamma coactiv

59 e dismutase, mitochondrial KATP channels and peroxisome proliferator activated receptor gamma coactiv

60 Peroxisome proliferator activated receptor-gamma coactiv

61 ssion, potentially through the regulation of peroxisome proliferator-activated receptor gamma coactiv

62 gnature genes uncoupling protein (UCP)-1 and peroxisome proliferator-activated receptor gamma coactiv

63 ets, Myc and the transcriptional coactivator peroxisome proliferator-activated receptor gamma coactiv

64 teins FOXO1, FOXO3A, and FOXO4 and decreased peroxisome proliferator-activated receptor gamma coactiv

65 We show that peroxisome proliferator-activated receptor gamma coactiv

66 Peroxisome proliferator-activated receptor gamma coactiv

67 of cyclic guanosine monophosphate (cGMP) and peroxisome proliferator-activated receptor gamma coactiv

68 of p38 MAPK decreased accumulation of active peroxisome proliferator-activated receptor gamma coactiv

69 Thus, we hypothesized that overexpression of peroxisome proliferator-activated receptor gamma coactiv

70 Peroxisome proliferator-activated receptor gamma coactiv

71 w here that the transcriptional coactivators peroxisome proliferator-activated receptor gamma coactiv

72 steoblast apoptosis that was associated with peroxisome proliferator-activated receptor gamma coactiv

73 nd ZR75.1 breast cancer cells, IGF-1 induces peroxisome proliferator-activated receptor gamma coactiv

74 ough AMP-activated protein kinase (AMPK) and peroxisome proliferator-activated receptor gamma coactiv

75 on directly through increased translation of peroxisome proliferator-activated receptor gamma coactiv

76 Here we demonstrate, unexpectedly, that peroxisome proliferator-activated receptor gamma coactiv

77 y, which is caused by a rapid degradation of Peroxisome proliferator-activated receptor gamma Coactiv

78 Peroxisome proliferator-activated receptor gamma coactiv

79 irisin precursor) and its upstream activator peroxisome proliferator-activated receptor gamma coactiv

80 Dietary iron modulates levels of peroxisome proliferator-activated receptor gamma coactiv

81 Peroxisome proliferator-activated receptor gamma coactiv

82 rial dysfunction via the sirtuin-1 (SIRT-1)/ peroxisome proliferator-activated receptor gamma coactiv

83 Peroxisome proliferator-activated receptor gamma coactiv

84 but was independent of the activation of the peroxisome proliferator-activated receptor gamma coactiv

85 of mitochondrial metabolism and biogenesis, peroxisome proliferator-activated receptor gamma coactiv

86 of hepatic and plasma glutamine, leading to peroxisome proliferator-activated receptor gamma coactiv

87 e cholesterol uptake liver receptor, whereas peroxisome proliferator-activated receptor gamma coactiv

88 e Huh7, the coexpression of the coactivators peroxisome proliferator-activated receptor gamma coactiv

89 Exercise training increased peroxisome proliferator-activated receptor gamma coactiv

90 I/R supported by an increased expression of peroxisome proliferator-activated receptor gamma coactiv

91 Clk2 phosphorylation of peroxisome proliferator-activated receptor gamma coactiv

92 y implicates the transcriptional coactivator peroxisome proliferator-activated receptor gamma coactiv

93 Peroxisome proliferator-activated receptor gamma coactiv

94 Transcriptional coactivators, peroxisome proliferator-activated receptor gamma coactiv

95 ess this, we analyzed DNA methylation in the peroxisome proliferator-activated receptor gamma coactiv

96 Accumulating evidence suggests that peroxisome proliferator-activated receptor gamma coactiv

97 The peroxisome proliferator-activated receptor gamma coactiv

98 genesis and OxPhos in part via inhibition of peroxisome proliferator-activated receptor gamma coactiv

99 y also increased expression of Sirtuin 1 and peroxisome proliferator-activated receptor gamma coactiv

100 egulation of the metabolic master regulator, peroxisome proliferator-activated receptor gamma coactiv

101 city are known to regulate and interact with peroxisome proliferator-activated receptor gamma coactiv

102 ed expression of PR domain containing 16 and peroxisome proliferator-activated receptor gamma coactiv

103 The transcriptional coactivator peroxisome proliferator-activated receptor gamma coactiv

104 ce; Akt3 affects subcellular localization of peroxisome proliferator-activated receptor gamma coactiv

105 anges increased intracellular ATP levels and peroxisome proliferator-activated receptor gamma coactiv

106 found a rapid and dynamic interplay between peroxisome proliferator-activated receptor gamma coactiv

107 role of MFN2's transcriptional coactivator, peroxisome proliferator-activated receptor gamma coactiv

108 Ralpha-HO-1 signaling involved PPARalpha and peroxisome proliferator-activated receptor gamma coactiv

109 onsequence of mutating stress coupled with a peroxisome proliferator-activated receptor gamma coactiv

110 Emerging data suggest that peroxisome proliferator-activated receptor gamma coactiv

111 The peroxisome proliferator-activated receptor gamma coactiv

112 ) and decreasing Sirtuin 1 activation of the peroxisome proliferator-activated receptor gamma coactiv

113 stress was associated with downregulation of peroxisome proliferator-activated receptor gamma coactiv

114 lism are under the control of members of the peroxisome proliferator-activated receptor gamma coactiv

115 Expression of peroxisome proliferator-activated receptor gamma coactiv

116 Peroxisome proliferator-activated receptor gamma coactiv

117 t was devoid of ERRgamma and the coregulator peroxisome proliferator-activated receptor gamma coactiv

118 Here we demonstrate that the coactivator peroxisome proliferator-activated receptor gamma coactiv

119 alpha, estrogen-related receptor alpha, and peroxisome proliferator-activated receptor gamma coactiv

120 production, likely by way of deactivation of peroxisome proliferator-activated receptor gamma coactiv

121 tably, the mitochondrial DNA copy number and peroxisome proliferator-activated receptor gamma coactiv

122 ouse, these UCP1(+) cells also expressed the peroxisome proliferator-activated receptor gamma coactiv

123 Peroxisome proliferator-activated receptor gamma coactiv

124 The transcriptional regulator peroxisome proliferator-activated receptor gamma coactiv

125 evels and the expression of four isoforms of peroxisome proliferator-activated receptor gamma coactiv

126 chondrial transcription factor A (TFAM), and peroxisome proliferator-activated receptor gamma coactiv

127 idrug resistance-associated protein 2 and 4, peroxisome proliferator-activated receptor gamma coactiv

128 uction and ATP levels, reduced expression of peroxisome proliferator-activated receptor gamma coactiv

129 ated the role of ERK1/2 on the expression of peroxisome proliferator-activated receptor gamma coactiv

130 n of the mitochondrial biogenesis regulators peroxisome proliferator-activated receptor-gamma coactiv

131 ctivated receptor-gamma coactivator 1-alpha, peroxisome proliferator-activated receptor-gamma coactiv

132 Peroxisome proliferator-activated receptor-gamma coactiv

133 Changes in the regulation of peroxisome proliferator-activated receptor-gamma coactiv

134 involving the master mitochondrial regulator peroxisome proliferator-activated receptor-gamma coactiv

135 latory proteins, and herein we identify that peroxisome proliferator-activated receptor-gamma coactiv

136 ke factor 15; myocyte enhancer factor 2, and peroxisome proliferator-activated receptor-gamma coactiv

137 d the AMP-activated protein kinase/sirtuin 1/peroxisome proliferator-activated receptor-gamma coactiv

138 Here we show that peroxisome proliferator-activated receptor-gamma coactiv

139 The coactivator peroxisome proliferator-activated receptor-gamma coactiv

140 Decreased peroxisome proliferator-activated receptor-gamma coactiv

141 The single nucleotide polymorphism in the peroxisome proliferator-activated receptor-gamma coactiv

142 ry banding model showed normal expression of peroxisome proliferator-activated receptor-gamma coactiv

143 a significantly decreased gene expression of peroxisome proliferator-activated receptor-gamma coactiv

144 The expression of multiple peroxisome proliferator-activated receptor-gamma coactiv

145 showed that GCs stimulate the expression of peroxisome proliferator-activated receptor-gamma coactiv

146 mediated by the transcriptional coactivator peroxisome proliferator-activated receptor-gamma coactiv

147 cal exercise and thyroid hormone mediate the peroxisome proliferator-activated receptor-gamma coactiv

148 Thyroid hormone promotes expression of peroxisome proliferator-activated receptor-gamma coactiv

149 PGC-1alpha (peroxisome-proliferator-activated receptor-gamma coactiv

150 tochondrial biogenesis regulator Pgc-1alpha (peroxisome proliferator-activated receptor gamma-coactiv

151 The expression of peroxisome proliferator-activated receptor gamma-coactiv

152 nd import of the transcriptional coactivator peroxisome proliferator-activated receptor gamma-coactiv

153 Additionally, mRNA levels for peroxisome proliferator-activated receptor-gamma-coactiv

154 ivated receptor-gamma-coactivator-1alpha and peroxisome proliferator-activated receptor-gamma-coactiv

155 e injections in rats were reported to induce peroxisome proliferator-activated receptor gamma-depende

156 gulating macrophage lipid metabolism through peroxisome proliferator-activated receptor gamma-depende

157 on of Zfp423, a transcriptional regulator of peroxisome proliferator-activated receptor gamma express

158 ory gene expression by negatively regulating peroxisome proliferator-activated receptor gamma express

159 -related genes and a persistent reduction in peroxisome proliferator-activated receptor-gamma express

160 that fuses paired box gene 8 (PAX8) with the peroxisome proliferator-activated receptor gamma gene (P

161 CBD enhanced the transcriptional activity of peroxisome proliferator-activated receptor gamma in luci

162 nase 2, 15-deoxy Delta-prostaglandin J2, and peroxisome proliferator-activated receptor gamma in this

163 pression of fatty acid binding protein 4 and peroxisome proliferator-activated receptor-gamma in adip

164 in-beta, interferon regulatory factor 4, and peroxisome proliferator-activated receptor-gamma in macr

165 Finally, application of a specific peroxisome proliferator-activated receptor gamma inhibit

166 that an interaction between STAT1, p300, and peroxisome proliferator-activated receptor-gamma is requ

167 ensive molecular dynamics simulations of the peroxisome proliferator-activated receptor-gamma LBD, in

168 BPD that is not dependent on the decrease in peroxisome proliferator-activated receptor gamma levels.

169 4(-/-) macrophages have relatively increased peroxisome proliferator-activated receptor-gamma levels

170 Unexpectedly, oxidized fatty acid peroxisome proliferator-activated receptor gamma ligands

171 nsport, possibly through oxidized fatty acid peroxisome proliferator-activated receptor gamma ligands

172 ant upregulation, in the lung mesenchyme, of peroxisome proliferator-activated receptor gamma (master

173 vation of arterial NADPH oxidase triggered a peroxisome proliferator-activated receptor-gamma-mediate

174 ease of a transferable factor able to induce peroxisome proliferator-activated receptor-gamma-mediate

175 roxynonenal) released from the heart trigger peroxisome proliferator-activated receptor-gamma-mediate

176 with markedly diminished ability to activate peroxisome proliferator-activated receptor gamma (MSDC-0

177 ation of the hypoxia-inducible factor-1alpha/peroxisome-proliferators-activated receptor-gamma pathwa

178 We studied interactions between polar bear peroxisome proliferator-activated receptor gamma (pbPPAR

179 Peroxisome proliferator-activated receptor gamma (PPAR-g

180 ng through the intracellular butyrate sensor peroxisome proliferator-activated receptor gamma (PPAR-g

181 CL10 and IL-6 transcript levels, and induced peroxisome proliferator-activated receptor gamma (PPAR-g

182 action between OmpA and Ecgp96 downregulates peroxisome proliferator-activated receptor gamma (PPAR-g

183 restored expression of the nuclear receptor peroxisome proliferator-activated receptor gamma (PPAR-g

184 Some nuclear receptors, including peroxisome proliferator-activated receptor-gamma (PPAR-g

185 reduced food intake and altered signaling by peroxisome proliferator-activated receptor-gamma (PPAR-g

186 n primary cultures, 2) likewise blocked by a peroxisome proliferator-activated receptor-gamma (PPAR-g

187 ress, namely the central insulin, klotho and peroxisome proliferator-activated receptor-gamma (PPAR-g

188 5-PGDH-derived 15-keto-PGE2 is an endogenous peroxisome proliferator-activated receptor-gamma (PPAR-g

189 Pb also increased skeletal expression of peroxisome proliferator-activated receptor-gamma (PPAR-g

190 wk with rosiglitazone, a specific agonist of peroxisome proliferator-activated receptor-gamma (PPAR-g

191 the upregulation of the transcription factor peroxisome proliferator-activated receptor-gamma (PPAR-g

192 Transcription factors responsive to peroxisome-proliferator-activated receptor gamma (PPAR-g

193 d their expression of a key adipogenic gene, peroxisome proliferator-activated receptor gamma (Pparg)

194 Peroxisome proliferator-activated receptor gamma (PPARG)

195 on of several of its target genes, including peroxisome proliferator-activated receptor gamma (PPARG)

196 een in a Pten-null background, we identified peroxisome proliferator-activated receptor gamma (Pparg)

197 Here, we show that peroxisome proliferator-activated receptor gamma (PPARG/

198 and transcription of ABCG1 and ABCA1 through peroxisome proliferator-activated receptor-gamma (PPARG)

199 e transporter, describe a novel role for the peroxisome proliferator-activated receptor-gamma (PPARG)

200 d patients with NAFLD, hepatic expression of peroxisome proliferator-activated receptor-gamma (PPARG)

201 cyte fate in vivo requires activation of the peroxisome proliferator activated receptor gamma (PPARga

202 sion of genes typifying the M2 phenotype and peroxisome proliferator activated receptor gamma (PPARga

203 e master pro-adipogenic transcription factor peroxisome proliferator activated receptor gamma (PPARga

204 f human chorionic gonadotropin (hCGbeta) and peroxisome proliferator activated receptor gamma (PPARga

205 chain amino acids (BCAA), and regulation of peroxisome proliferator activated receptor gamma (PPARga

206 ty to activate the nuclear hormone receptor, peroxisome proliferator activated receptor gamma (PPARga

207 The nuclear receptor peroxisome proliferator activated receptor gamma (PPARga

208 Peroxisome proliferator activated receptor-gamma (PPARga

209 ificant alterations in pathways regulated by peroxisome proliferator activated receptor-gamma (PPARga

210 their direct action on the nuclear receptor peroxisome proliferator-activated receptor gamma (PPARga

211 ative DNA binding behavior of the adipogenic peroxisome proliferator-activated receptor gamma (PPARga

212 describe here a regulatory circuit in which peroxisome proliferator-activated receptor gamma (PPARga

213 y activation of the nuclear hormone receptor peroxisome proliferator-activated receptor gamma (PPARga

214 Peroxisome proliferator-activated receptor gamma (PPARga

215 Here, we have shown that the peroxisome proliferator-activated receptor gamma (PPARga

216 Peroxisome proliferator-activated receptor gamma (PPARga

217 ich was recruited to the promoter of Nox1, a peroxisome proliferator-activated receptor gamma (PPARga

218 iated macrophage differentiation by cleaving peroxisome proliferator-activated receptor gamma (PPARga

219 Long-term exposure to peroxisome proliferator-activated receptor gamma (PPARga

220 reduced by concomitant administration of the peroxisome proliferator-activated receptor gamma (PPARga

221 The nuclear receptor peroxisome proliferator-activated receptor gamma (PPARga

222 such as rosiglitazone and pioglitazone, are peroxisome proliferator-activated receptor gamma (PPARga

223 element-binding protein H (CREBH) but not by peroxisome proliferator-activated receptor gamma (PPARga

224 Using mice with a conditional deletion of peroxisome proliferator-activated receptor gamma (PPARga

225 Peroxisome proliferator-activated receptor gamma (PPARga

226 Peroxisome proliferator-activated receptor gamma (PPARga

227 er type 4 (GLUT4), lipoprotein lipase (LpL), peroxisome proliferator-activated receptor gamma (PPARga

228 An important player in their pathogenesis is peroxisome proliferator-activated receptor gamma (PPARga

229 e contaminants act via the activation of the peroxisome proliferator-activated receptor gamma (PPARga

230 As), which are unique endogenous agonists of peroxisome proliferator-activated receptor gamma (PPARga

231 ated the key adipogenic transcription factor peroxisome proliferator-activated receptor gamma (PPARga

232 decreasing the recruitment of the adipogenic peroxisome proliferator-activated receptor gamma (PPARga

233 We hypothesized that pioglitazone, a peroxisome proliferator-activated receptor gamma (PPARga

234 vel co-activator of the transcription factor peroxisome proliferator-activated receptor gamma (PPARga

235 Certain ligands for peroxisome proliferator-activated receptor gamma (PPARga

236 at vitamin D downregulates the proadipogenic peroxisome proliferator-activated receptor gamma (PPARga

237 the actions in pulmonary epithelial cells of peroxisome proliferator-activated receptor gamma (PPARga

238 Peroxisome proliferator-activated receptor gamma (PPARga

239 on and subsequent proteasomal degradation of peroxisome proliferator-activated receptor gamma (PPARga

240 O cells are rescued by ectopic expression of peroxisome proliferator-activated receptor gamma (PPARga

241 components of FM550 are biologically active peroxisome proliferator-activated receptor gamma (PPARga

242 e consistent with the negative regulation of peroxisome proliferator-activated receptor gamma (PPARga

243 and others have shown that activation of the peroxisome proliferator-activated receptor gamma (PPARga

244 Phosphorylation of peroxisome proliferator-activated receptor gamma (PPARga

245 ysis revealed a significant up-regulation of peroxisome proliferator-activated receptor gamma (PPARga

246 Peroxisome proliferator-activated receptor gamma (PPARga

247 tion depends on interactions between Sp1 and peroxisome proliferator-activated receptor gamma (PPARga

248 pocyte differentiation via the activation of peroxisome proliferator-activated receptor gamma (PPARga

249 e of the JCI, Shan and colleagues found that peroxisome proliferator-activated receptor gamma (PPARga

250 Peroxisome proliferator-activated receptor gamma (PPARga

251 Peroxisome proliferator-activated receptor gamma (PPARga

252 iscovered that palmitic acid (PA), a natural peroxisome proliferator-activated receptor gamma (PPARga

253 uration are governed by the nuclear receptor peroxisome proliferator-activated receptor gamma (PPARga

254 tration-dependent pathway was independent of peroxisome proliferator-activated receptor gamma (PPARga

255 WISP2 forms a cytosolic complex with the peroxisome proliferator-activated receptor gamma (PPARga

256 The nuclear receptor peroxisome proliferator-activated receptor gamma (PPARga

257 The nuclear receptor peroxisome proliferator-activated receptor gamma (PPARga

258 Peroxisome proliferator-activated receptor gamma (PPARga

259 f natural products with high affinity to the peroxisome proliferator-activated receptor gamma (PPARga

260 miR-503 expression is directly regulated by peroxisome proliferator-activated receptor gamma (PPARga

261 und that this defect is because of defective peroxisome proliferator-activated receptor gamma (PPARga

262 Peroxisome proliferator-activated receptor gamma (PPARga

263 We have recently shown that peroxisome proliferator-activated receptor gamma (PPARga

264 In contrast, the master adipogenic TF peroxisome proliferator-activated receptor gamma (PPARga

265 Peroxisome proliferator-activated receptor gamma (PPARga

266 ancer-binding protein alpha (C/EBPalpha) and peroxisome proliferator-activated receptor gamma (PPARga

267 The nuclear receptor peroxisome proliferator-activated receptor gamma (PPARga

268 A class of small molecules-peroxisome proliferator-activated receptor gamma (PPARga

269 pha), C/EBPbeta, C/EBPdelta, KLF5, KLF9, and peroxisome proliferator-activated receptor gamma (PPARga

270 Peroxisome proliferator-activated receptor gamma (PPARga

271 d the extracellular matrix, particularly the peroxisome proliferator-activated receptor gamma (Pparga

272 Peroxisome Proliferator-Activated Receptor Gamma (PPARga

273 lipid droplet formation and the induction of peroxisome proliferator-activated receptor gamma (PPARga

274 gh levels of TNF and IL-12 but low levels of peroxisome proliferator-activated receptor gamma (PPARga

275 anoparticle (NP) platforms to deliver either Peroxisome Proliferator-Activated Receptor gamma (PPARga

276 ctor for transcription factors including the peroxisome proliferator-activated receptor-gamma (PPARga

277 nes, antidiabetic drugs that are agonists of peroxisome proliferator-activated receptor-gamma (PPARga

278 Peroxisome proliferator-activated receptor-gamma (PPARga

279 Here we show that dietary SCFAs induce a peroxisome proliferator-activated receptor-gamma (PPARga

280 D challenge revealed that the mRNA levels of peroxisome proliferator-activated receptor-gamma (PPARga

281 the 15-keto-prostaglandin E2 (15-keto-PGE2)/peroxisome proliferator-activated receptor-gamma (PPARga

282 188-3p expression was upregulated by 2-AG or peroxisome proliferator-activated receptor-gamma (PPARga

283 The peroxisome proliferator-activated receptor-gamma (PPARga

284 as a consequence of increased expression of peroxisome proliferator-activated receptor-gamma (PPARga

285 tizers that act through the nuclear receptor peroxisome proliferator-activated receptor-gamma (PPARga

286 TEN may be regulated by the nuclear receptor peroxisome proliferator-activated receptor-gamma (PPARga

287 13.1 treatment were associated with enhanced peroxisome proliferator-activated receptor-gamma (PPARga

288 Peroxisome proliferator-activated receptor-gamma (PPARga

289 X receptors alpha and beta (LXRalpha,beta), peroxisome proliferator-activated receptor-gamma (PPARga

290 but improvement of insulin resistance using peroxisome proliferator-activated receptor-gamma (PPARga

291 al interactions between prenatal DHA and the peroxisome proliferator-activated receptor-gamma (PPARga

292 The expression of placental peroxisome proliferator-activated receptor gamma (r = -0

293 vo, that miR-130/301-specific control of the peroxisome proliferator-activated receptor gamma regulat

294 of weight loss was not driven by changes of peroxisome proliferator-activated receptor gamma sensiti

295 phosphatases, and ameliorated activation of peroxisome proliferator-activated receptor gamma/sterol

296 c-Jun N-terminal kinase, thereby inhibiting peroxisome proliferator-activated receptor gamma through

297 Notably, I148M cells display reduced peroxisome proliferator-activated receptor gamma transcr

298 in-beta, interferon regulatory factor 4, and peroxisome proliferator-activated receptor-gamma, was de

299 (-/-) OPCs with cholesterol or activation of peroxisome proliferator-activated receptor-gamma with pi

300 rs (CCAAT/enhancer binding protein alpha and peroxisome proliferator-activated receptor gamma) within